Viome, a health diagnostics and microbiome company, has raised $25 million in Series D funding and appointed Kal Raman as COO. The company plans to expand its diagnostics division, particularly its CancerDetect test for oral and throat cancer, which has received breakthrough device designation from the FDA. Viome also aims to develop tests for conditions like IBS and IBD. CEO Naveen Jain, Viome’s founder, has raised $200 million to date, with investors including Khosla Ventures and Salesforce’s Marc Benioff.
Keep Reading
Add A Comment